MyndTec Completes Ninth Tranche of Private Placement

MyndTec, Inc. ( (TSE:MYTC) ) has provided an update.

MyndTec Inc. has completed the ninth tranche of its non-brokered private placement, raising $110,785.20 through the issuance of 553,926 units, each comprising one common share and a half-share purchase warrant. The proceeds will be used for general corporate purposes, including working capital and development initiatives. This tranche is part of a larger offering that has raised nearly $944,000 in total. The transaction involves related parties, constituting a ‘related party transaction’ under Canadian securities regulations, but is exempt from certain formal requirements due to the company’s market status and the transaction’s value.

Spark’s Take on TSE:MYTC Stock

According to Spark, TipRanks’ AI Analyst, TSE:MYTC is a Underperform.

MyndTec, Inc. faces significant financial challenges, with substantial risks due to negative equity and persistent losses, which weigh heavily on its overall score. Despite some positive momentum from a recent private placement initiative, the technical indicators suggest a bearish trend, and the absence of key valuation metrics further limits investor appeal. Collectively, these factors contribute to a low overall score, indicating caution for potential investors.

To see Spark’s full report on TSE:MYTC stock, click here.

More about MyndTec, Inc.

MyndTec is a CSE-listed medical technology company specializing in neurostimulation to aid in restoring function and improving treatment for individuals with central nervous system diseases, disorders, and damage, such as Parkinson’s disease, Alzheimer’s disease, and stroke. The company has developed the MyndMove™ system, a non-invasive intervention using functional electrical stimulation to promote neuroplasticity and help patients regain voluntary movement and independence.

Average Trading Volume: 20,512

Technical Sentiment Signal: Sell

Find detailed analytics on MYTC stock on TipRanks’ Stock Analysis page.